Trinity Innovation Bioventure Singapore is a licensed biomed venture capital fund focusing on innovation and value investment with deep insight and experience on Asia markets.
We are part of the Trinity Innovation Fund group, founded in 2018, managing multiple VC funds in the region.
We are an experienced team led by industrial veterans who have managed multiple VC funds and invested over dozens of biotech companies.
Our Strength
- Access to China market through synergy with TIF: Two organizations, One Team
- Multi-dimensional value-added post investment to enhance possibility of success and returns
- Clear investment thesis: In Asia, for Global; Leverage regional synergy and realize future value
- Best-in-class team in biomed investment with strong track record
Our Focus
TIBS seeks to invest and build great companies that emerging biotechnology leads to innovative therapeutics to address global unmet medical needs.
We focus on incubating and growing potential early-stage biotech start-ups with breakthrough platform technology, differentiated scientific merit and commercial value.
Our Core Competency
- Value Discovery: Select investment projects based on precise judgements from in-depth research
- Project Incubation: Incubate cutting-edge science or outstanding entrepreneurs with innovative approaches. Unique incubation strategy:
- project management by investment team to increase the asset value;
- management team recruitment to maximize the equity value and capital efficiency
- Help entrepreneurs to grow rapidly with proprietary foresight, industry understanding and resources